Home / April 18- April 24, 2026 / MIND & BODY, HEART & SOUL / CHEMICAL RESTRAINT IN ELDERS A convenient solution or a dangerous short cut? By Dr Amit Dias, MD
CHEMICAL RESTRAINT IN ELDERS A convenient solution or a dangerous short cut? By Dr Amit Dias, MD
No Comments on CHEMICAL RESTRAINT IN ELDERS A convenient solution or a dangerous short cut? By Dr Amit Dias, MD

CHEMICAL RESTRAINT IN ELDERS A convenient solution or a dangerous short cut? By Dr Amit Dias, MD

April 18- April 24, 2026, MIND & BODY, HEART & SOUL April 17, 2026 , by

As global experts gather in Lyon for the Alzheimer’s Disease International Conference 2026 under the theme “Solutions for Today and Tomorrow,” dementia care has rightly taken center stage. Yet, beyond the discussions on innovation and policy, there exists a quieter, deeply troubling reality — one that unfolds daily in homes and healthcare settings across the world where elders are subdued not by their illness, but by medications. This invited article examines the ethics of chemical restraint in senior citizens — an issue that is often overlooked, under-reported, and, in many cases, normalized.

The Invisible Restraint
CHEMICAL restraint refers to the use of medications not primarily to treat a diagnosed condition, but to control behavior — such as agitation, wandering, aggression, or insomnia.
Unlike physical restraint, like chains and ropes, it leaves no visible marks. There are no tied hands or locked doors — only a quiet, subdued patient. Commonly used drugs include antipsychotics, benzodiazepines, and sedatives. While these medications have legitimate clinical uses, their application as tools of behavioral control raises serious concerns.
This form of restraint is particularly insidious because it is easily justified as “treatment,” making it less likely to be questioned by families or even healthcare providers.

A Convenient Solution—or a Dangerous Shortcut?
CONSIDER a common scenario: an elderly person with dementia becomes restless at night, calling out or wandering. The family, already exhausted, seeks help. A sedative is prescribed. The nights become quieter. The patient sleeps. But over time, the person begins to sleep through the day, loses interest in food and conversation, and gradually withdraws from life. What appears to be improvement is, in reality, suppression. Worse still is the fact that often the people around them increase the dose on their own to chemically restrain them not aware of the serious adverse effects.
Scientific evidence shows that such use of chemical restraint and unnecessary drugs can increase the risk of falls, fractures, cognitive decline, stroke, and even mortality —especially among individuals with dementia.

The Ethical Fault Line
 The use of chemical restraint sits at a critical ethical crossroads.
• Autonomy vs Control – Sedation removes a person’s ability to act, think, and express themselves freely.
• Beneficence vs Harm – Intended to reduce risk, these medications often introduce new and serious dangers.
• Dignity vs Manageability – A quiet patient may be easier to care for, but may also have lost their identity and agency.
The challenge lies in recognizing that making care easier should never come at the cost of a person’s dignity.

The Legal Reality
IN India, the Mental Healthcare Act, 2017 provides clear safeguards. It permits the use of restraint only when absolutely necessary to prevent immediate harm, and even then under strict supervision, documentation, and for the shortest duration possible.
 Unjustified chemical restraint may violate the fundamental right to life and personal liberty under Article 21 of the Constitution.
Furthermore, the inappropriate use of sedative or antipsychotic medications without clear indication can be classified as elder abuse, exposing caregivers and practitioners to legal consequences.

Where Misuse Begins
IN my research in Goa, I noticed that in many cases, chemical restraint is not driven by malice, but by circumstance. Caregiver fatigue, lack of awareness about dementia, limited access to trained professionals, and social attitudes that equate quietness with good care all contribute to its misuse. I often saw this during our community research on dementia and elders with depression.
Medication becomes a convenient solution — a way to manage behavior quickly, without addressing underlying causes. However, this approach often reflects a failure to understand the condition itself.

Common Dilemmas: Practical Solutions
THESE everyday scenarios help put chemical restraint into perspective. The names have been changed to maintain confidentiality—but the situations are all too real.

The Silent Day
Seventy-eight-year-old Anthony Pereira was prescribed sedatives for insomnia. What began as a seemingly simple solution gradually led to a troubling decline. He became withdrawn, inactive, and disengaged. His worsening memory was attributed to the natural progression of disease — but in reality, the medication was playing a significant role in accelerating his deterioration.

What is Chemical Restraint? What are “Unnecessary Drugs”?

Chemical restraint is the use of medications to control behaviour—such as agitation, wandering, or resistance—rather than to treat a diagnosed medical condition.
“Unnecessary drugs” are those NOT used for treatment or patient safety. This includes medications given:
• To make a patient easier to manage
• In excessive doses or for prolonged periods
• Despite risks from existing illnesses or drug interactions
Using medication for convenience rather than care crosses the line from treatment to restraint—and may be both unethical and illegal.

What could have been done instead?
 Anthony did not need to be “put to sleep”—he needed his sleep understood.
• Establishing a structured sleep routine (fixed bedtime, limiting daytime naps)
• Ensuring daytime physical activity and sunlight exposure
• Reducing evening stimulation (noise, screen time, heavy meals)
• Identifying triggers like pain, urinary urgency, or anxiety
• Using comfort measures — a familiar voice, calming music, or a night lamp
Often, insomnia in the elderly is not a disease — but a signal. Addressing its cause can restore sleep without suppressing the person.

The “Aggressive” Patient
Sunita Mayenkar, a 72-year-old woman with dementia, resisted bathing. She was quickly labelled “aggressive” and started on antipsychotic medication. Yet, the real issue was not aggression — it was fear, discomfort, and loss of control.
 Bathing, for a person with dementia, can be confusing and even frightening. The environment, the temperature, unfamiliar handling — everything can feel threatening.

What could have been done instead?
 • Using a familiar caregiver and maintaining privacy
• Explaining each step in simple, reassuring language
• Allowing choice and control (time of bath, type of clothing)
• Ensuring comfortable water temperature and a non-threatening environment
• Breaking the task into smaller, manageable steps
• Using distraction—music, conversation, or even humour
We instinctively use such techniques with children. The same empathy and creativity must extend to our elders. Medication should not replace patience.

The Alzheimer’s Disease International Conference in Lyon 14-16 April 2026: Solutions for Today & Tomorrow

Person-Centered Care: The Real Solution
 The way forward lies in embracing person-centered care, an approach that aligns closely with the theme of the ADI conference this year.
This involves:
• Understanding the individual’s history, preferences, and personality
• Creating a safe and familiar environment
• Using reassurance, empathy, and communication
• Identifying and addressing triggers such as pain, hunger, or loneliness
Simple, non-pharmacological interventions—structured routines, meaningful activities, and supportive environments—can significantly reduce behavioral symptoms.

Solution for Today & Tomorrow
Addressing chemical restraint requires coordinated action:
• Education & Awareness: Families must understand that behaviors are not intentional and should not be managed only with medication.
• Caregiver Support: Respite care and community services can reduce burnout and dependence on sedatives.
• Responsible Prescribing: Avoid quick-fix drugs; ensure regular review and deprescribing.
• Policy & Monitoring: Strengthen guidelines, documentation, and accountability—even at home.
• Non-Drug Interventions: Prioritize psychosocial care—music, environment, and engagement.
Our work in Goa through the Dementia Home Care project, laid the foundation and provide the evidence for Psychosocial Interventions for families of people with dementia.

Conclusion
CHEMICAL restraint is one of the most subtle yet significant ethical issues in elder care today. Its effects are profound, often hidden, and frequently misunderstood. The call for “Solutions for Today and Tomorrow” must extend beyond innovation to include compassion, awareness, and accountability. Because the true measure of care is not how manageable a patient becomes, but how well their dignity is preserved.

No related posts.

Search

Back to Top